Anticoagulation in Coronary Intervention

Publié dans European Heart Journal 2016 Dec;37:3376–3385 Auteurs : Zeymer U, Rao SV, Montalescot G. Article disponible en consultant le site Abstract Percutaneous coronary intervention (PCI) induces thrombin generation and is associated with the risk of acute, subacute, or long-term ischaemic events. Therefore, intravenous anticoagulation is recommended to minimize thrombotic complications. The intensity and duration…

TCT-160 Impact of admission during ON vs. OFF hours in unselected ST-Elevation Myocardial Infarction Patients treated with Primary Percutaneous Coronary Intervention.

TCT-160 Impact of admission during ON vs. OFF hours in unselected ST-Elevation Myocardial Infarction Patients treated with Primary Percutaneous Coronary Intervention. Publié dans Journal of the American College of Cardiology, le 01 novembre 2016. En savoir plus en consultant le site. Auteurs : Anis SAIB, Laurent PAYOT, Mathieu KERNEIS, Olivier BARTHELEMY, Jean-Philippe COLLET, Claude LE FEUVRE,…

Prasugrel versus clopidogrel in acute coronary syndromes treated with PCI : Effects on clinical outcome according to culprit artery location

Publié dans International Journal of Cardiology 2016 Nov 15;223:632-638 Auteurs : De Servi S, Goedicke J, Ferlini M, Palmerini T, Syvänne M, Montalescot G. Article disponible en consultant le site Abstract Background and aim : Acute coronary syndrome (ACS) mortality increases when the culprit lesion is in the left anterior descending (LAD) artery. We investigated…

Reply : Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction : Who Benefits ?

Publié dans Journal of the American College of Cardiology 2016 Nov 15;68(20):2241-2242 Auteurs : Beygui F, Montalescot G, ALBATROSS Investigators. Article disponible en consultant le site Letter The letter by Drs. Weir and Petrie points to the hypothetic benefit of mineralocorticoid receptor blockade (MRA) in preventing left ventricular remodeling and reducing mortality in patients with…